#CNBC Guggenheim Partner’s Seamus Fernandez: Oral weight loss pill ‘meaningful step up’ for Eli Lilly
Guggenheim Partner’s Seamus Fernandez: Oral weight loss pill ‘meaningful step up’ for Eli Lilly
Seamus Fernandez, Guggenheim Partners biotech analyst, joins CNBC’s ‘Squawk on the Street’ to discuss the latest data on Eli Lilly’s obesity pill.
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
#MILENIO
コメントを送信